Amdocs (DOX) reported $1.16 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.1%. EPS of $1.81 for the same period compares to $1.66 a year ago.
The reported revenue represents a surprise of +0.32% over the Zacks Consensus Estimate of $1.15 billion. With the consensus EPS estimate being $1.75, the EPS surprise was +3.28%.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Amdocs performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:View all Key Company Metrics for Amdocs here>>>
Shares of Amdocs have remained unchanged over the past month versus the Zacks S&P 500 composite's +1.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| Sep-03 | |
| Aug-19 | |
| Aug-06 | |
| Aug-06 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Aug-05 | |
| Jul-15 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite